Design of VA Cooperative Study #591: CERV-PTSD, comparative effectiveness research in veterans with PTSD.

Published

Journal Article

CERV-PTSD is a randomized controlled trial of two of the most effective treatments for PTSD, Prolonged Exposure (PE) and Cognitive Processing Therapy (CPT). Despite solid evidence that both treatments are effective, there is limited evidence about their effectiveness relative to one another. The primary objective is to compare the effectiveness of PE and CPT for reducing PTSD symptom severity in a healthcare system that offers both treatments. The secondary objective is to compare the effectiveness of PE and CPT for reducing the severity of comorbid mental health problems and service utilization as well as improving functioning and quality of life. The tertiary objective is to examine whether discrepancy between patient preferences and treatment assignment reduces the effectiveness of each treatment. Exploratory analyses will examine whether demographic and clinical characteristics predict differential response to PE and CPT. The study is designed to randomize 900 male and female veterans with PTSD due to any traumatic military event to receive PE or CPT. The standard dose of treatment is 12 weekly sessions but veterans who improve more rapidly may finish in fewer sessions and veterans who improve more slowly may have additional sessions. The primary outcome is improvement in PTSD symptoms, measured during and after treatment and then 3 and 6 months later. As a large multi-site trial with men and women, CERV-PTSD is designed to advance the delivery of care for PTSD by providing conclusive information about whether one treatment is better than the other, overall, and for different types of patients.

Full Text

Duke Authors

Cited Authors

  • Schnurr, PP; Chard, KM; Ruzek, JI; Chow, BK; Shih, M-C; Resick, PA; Foa, EB; Marx, BP; Huang, GD; Lu, Y

Published Date

  • March 2015

Published In

Volume / Issue

  • 41 /

Start / End Page

  • 75 - 84

PubMed ID

  • 25457792

Pubmed Central ID

  • 25457792

Electronic International Standard Serial Number (EISSN)

  • 1559-2030

Digital Object Identifier (DOI)

  • 10.1016/j.cct.2014.11.017

Language

  • eng

Conference Location

  • United States